D-1188-2018 Class III Terminated

Recalled by United Therapeutics Corp. — Durham, NC

FDA drug recall D-1188-2018 was initiated by United Therapeutics Corp. on Aug 14, 2018 and is designated Class III. Reason for recall: Defective Delivery System: Water ingress through the lower water cup sensor of the device. The recall status is terminated (terminated Oct 30, 2019). Affected quantity: 2801 devices.

Recall details

Product Type
Drugs
Report Date
Sep 19, 2018
Initiation Date
Aug 14, 2018
Termination Date
Oct 30, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2801 devices

Product description

Tyvaso Inhalation System Patient a) Starter Kit with TYVASO (treprostinil) Inhalation Solution. Treprostinil 1.74 mg/2.9 mL (0.6 mg/mL) (NDC 66302-206-01) b) TD-300/A Replacement Device Kit Material Number RTP3099 RX Only. Manufactured by United Therapeutics Corporation Research Triangle Park, NC 27709

Reason for recall

Defective Delivery System: Water ingress through the lower water cup sensor of the device.

Distribution pattern

IL, PA

Code information

Lot number a) 2101503, 2101507, 2101523, 2101532, 2101533, EXP 07/31/2019; 2101557, EXP 11/30/2019 b) Lot # 2101504, EXP 4/24/2021; 2101509, 2101522, EXP 5/8/2021; 2101531, EXP 5/15/2021; 2101534, EXP 6/10/2021; 2101543, EXP 6/14/2021; 2101558, EXP 7/26/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1188-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1188-2018. Report a data issue: hello@regdatalab.com.